Farringdon Capital’s QuidelOrtho QDEL Stock Holding History

Farringdon Capital’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,929	Closed	-$309K	–	560
2024 Q4	$309K	Buy	+6,929	New	+$283K	0.13%	273

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Farringdon Capital's QDEL Position: Q1 2025 in Review

Farringdon Capital sold out of QuidelOrtho (QDEL) in Q1 2025, closing a stake of 6,929 shares — an estimated $309K sold.

Farringdon Capital first reported a position in QDEL in Q4 2024 and held it in 1 quarter. The position peaked at $309K in Q4 2024. 265 funds tracked by Wall St. Rank hold QDEL as of Q1 2025.

Farringdon Capital reported no remaining QuidelOrtho position as of Q1 2025 after selling out during the quarter.
Farringdon Capital sold 6,929 QuidelOrtho shares in Q1 2025, an estimated $309K.
Farringdon Capital first reported a position in QuidelOrtho in Q4 2024 and held it in 1 quarter.
Farringdon Capital's QuidelOrtho position peaked at $309K in Q4 2024.
265 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2025.

Based on Farringdon Capital's 13F filing for Q1 2025, filed 15 May 2025.